Pharmacological inhibition in the ataxia telangiectasia and Rad3-connected protein serine/threonine kinase (ATR; also referred to as FRAP-related protein (FRP1)) has emerged to be a promising approach for most cancers cure that exploits synthetic lethal interactions with proteins involved with DNA damage repair, overcomes resistance to other therapies and improves antitumour https://andyj654ufk5.worldblogged.com/profile